Skip to main content

Table 2 Mean first day glucose (Glu 1 , in mmol/L) in patients during the two study periods

From: Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

 

Before NICE-SUGAR

After NICE-SUGAR

P

All patients

7.96 (2.95)

8.03 (2.92)

<0.0001

Surgical patients

7.8 (2.2)

7.9 (2.2)

<0.0001

Medical patients

8.1 (3.6)

8.2 (3.5)

0.002

IDDM patients

10.8 (5.3)

11.2 (5.4)

<0.0001

Non-IDDM patients

7.8 (2.7)

7.8 (2.7)

<0.0001

Patients with >48 h ICU stay

8.2 (3.0)

8.3 (2.9)

<0.0001

Patients with <48 h ICU stay

7.8 (2.9)

7.9 (2.9)

<0.0001

  1. All numbers are mean (SD). IDDM, insulin-dependent diabetes mellitus; NICE-SUGAR, Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation.
Back to article page

Critical Care

ISSN: 1364-8535